Dr. Kyle E. Smoot, MD

Dr. Smoot practices at Providence Medical Group in Portland, Oregon.

Dr. Smoot's NPI, 1124170063, was assigned on January 18, 2007. Dr. Smoot graduated from Cincinnati College of Medicine and Surgery in 2000. Dr. Smoot holds Oregon license MD24410.

Dr. Smoot's primary practice is Providence Medical Group, at 9155 SW Barnes Rd, Portland, OR 97225 in Washington County. The practice phone is (503) 216-1150.

Dr. Smoot's primary practice is Providence Medical Group in Portland, Oregon. Dr. Smoot is also affiliated with Providence St. Vincent Medical Center. The medical group on file is Providence Medical Group, Oregon. Dmand AI also links Dr. Smoot to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smoot practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Smoot's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Smoot is licensed in Oregon.

CMS data shows 322 Medicare services from Dr. Smoot across 3 procedure codes in 2024, for 141 Medicare patients. Medicare paid $20,254 for them. Every service was in an office.

CMS counts 141 Medicare patients who saw Dr. Smoot in 2024. The largest group is 65 to 74, with 60 patients. 48% of them have high cholesterol, and 45% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smoot's median patient age at 58, with 74% women.

In 2024, Dr. Smoot wrote 2,625 Medicare Part D claims for 361 patients. 89% of them were for generic drugs. CMS names the drug for 2,334 of them, across 55 drugs with 11 or more claims each, at $1,628,405 in total drug cost. In 2023, CMS named 2,260 claims across 56 drugs.

Dr. Smoot accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smoot as offering telehealth.

Dmand AI links 13 papers to Dr. Smoot, published from 2017 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Multiple Sclerosis, Relapsing-Remitting, Dimethyl Fumarate and Multiple Sclerosis. Dr. Smoot has published most often in Mult Scler. Dr. Smoot's most frequent co-authors are Stanley L. Cohan, MD, Kiren Jean Kresa-Reahl, MD and Pavle Repovic, MD, PhD.

Dmand AI links Dr. Smoot to 9 clinical trials, 2 of them phase 3 studies. Conditions studied include Multiple Sclerosis, Demyelinating Autoimmune Diseases, CNS and Multiple Sclerosis, Relapsing-Remitting. Providence Health & Services sponsors the most, 5. Open Payments lists research payments to Dr. Smoot that name 1 trial.

CMS Open Payments shows 1,499 general payments to Dr. Smoot from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. EMD Serono, Inc. paid the most, $481,815. It also lists 13 research payments totaling $1,088 from 2019 to 2021, naming 1 clinical trial.

Dr. Smoot graduated from Cincinnati College of Medicine and Surgery in 2000.